fashion -WSS

fashion

author：knowledge 2025-09-08 11:05:22 - browse：4

Amylyx founders — Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Change Healthcare cyberattack outage could last weeks

knowledge

WSS

Pfizer highlights cancer drugs it thinks could reignite investor interest

UnitedHealth argues against case alleging wrongful AI care denials

Study finds gene variants tied to breast cancer risk in Black women

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Covid isolation guidance eased by the CDC

Bird flu surveillance in wastewater gets boost from consortium

hotspot

fashion

entertainment

ChatGPT in medicine: STAT answers readers' burning questions

Biotech companies concerned about China biosecurity crackdown

Trump demands the U.S. pay no more for drugs than other countries … again

International team creates first chimeric human

FDA approval of Sarepta Duchenne genetic therapy gives me hope

ASCO eve: Let’s set the table for this year's meeting

Dobbs anniversary: the lost opportunity of abortion as health care

FDA poised to publish guidelines for clinical trial diversity

Continuity nursing helped my family in our darkest PICU moments

As a primary care physician, here's how I hope to partner with AI

entertainment

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

How to address the problem of discarded donor organs

Flu vaccine offering decent levels of protection this winter, new data show

Covid isolation guidance eased by the CDC

How to address the problem of discarded donor organs

Congress gives doctors Medicare pay bump

knowledge

Wikipedia

knowledge

knowledge